Tiffany Sepp

President and CEO at Vanguard Clinical

Tiffany Sepp has a wealth of experience in clinical operations and research. Tiffany began their career in 2005 as a Senior Research Associate at the University of California, San Diego. In 2006, they moved to Covance, Inc. as a Clinical Study Manager. Tiffany then worked as a Clinical Research Associate at PPD, Inc. in 2007. In 2008, they were a Clinical Trials Manager at both Cardium Therapeutics and Tissue Repair Company. From 2009 to 2011, they were a Clinical Operations Manager at Advanced BioHealing, and a Sr. Clinical Research Manager - Early Phase Oncology at Millennium Pharmaceuticals from 2011 to 2013. In 2013, they joined Histogenics Corporation as a Director of Clinical Operations, and in 2012, they became President and CEO of Vanguard Clinical Inc.

Tiffany Sepp attended UC San Diego from 2000 to 2005, during which time they earned a Bachelor of Science in Biology, General and a Bachelor of Arts in English Literature (British and Commonwealth).

Links

Previous companies

Histogenics logo

Timeline

  • President and CEO

    May, 2012 - present